Abbott Laboratories - 45 Year Stock Price History | ABT

Historical daily share price chart and data for Abbott Laboratories since 1980 adjusted for splits and dividends. The latest closing stock price for Abbott Laboratories as of June 30, 2025 is 136.01.
  • The all-time high Abbott Laboratories stock closing price was 139.57 on March 03, 2025.
  • The Abbott Laboratories 52-week high stock price is 141.23, which is 3.8% above the current share price.
  • The Abbott Laboratories 52-week low stock price is 99.71, which is 26.7% below the current share price.
  • The average Abbott Laboratories stock price for the last 52 weeks is 121.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Abbott Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 129.2294 112.3270 139.5740 110.5880 136.0100 21.44%
2024 109.4921 106.6400 118.2190 98.6193 112.0010 4.82%
2023 100.3711 104.2910 110.6580 87.5542 106.8530 2.26%
2022 105.6407 130.1450 130.1450 90.4720 104.4910 -20.68%
2021 113.0777 100.5750 132.4110 98.2675 131.7370 30.53%
2020 88.1119 78.9048 105.4700 57.2496 100.9260 28.04%
2019 72.6421 62.0404 80.2076 59.1125 78.8231 22.08%
2018 56.9448 51.5355 66.2985 49.5623 64.5667 29.06%
2017 42.2197 33.4552 50.3784 33.4552 50.0277 52.03%
2016 34.3500 35.8762 38.5560 30.5607 32.9069 -12.32%
2015 38.3680 36.7448 42.5423 32.4551 37.5309 1.87%
2014 33.2384 30.6010 37.9478 28.8564 36.8430 20.08%
2013 28.3575 25.2422 30.9852 25.2422 30.6811 23.96%
2012 23.4390 20.7568 27.2569 19.9868 24.7515 20.28%
2011 18.4234 16.8677 20.6140 16.0769 20.5775 21.76%
2010 17.6479 18.5849 19.3322 15.8965 16.8995 -8.28%
2009 16.3096 17.6837 19.0385 13.9327 18.4245 4.56%
2008 18.0169 17.9619 19.6061 16.3267 17.6209 -2.49%
2007 17.3508 15.3918 18.9564 15.3918 18.0714 18.04%
2006 14.0123 12.1058 15.4538 12.1058 15.3101 26.85%
2005 13.7500 13.9568 15.1190 11.5181 12.0690 -13.49%
2004 11.9993 11.8717 14.0525 10.0516 13.9508 17.89%
2003 10.3820 9.9185 11.9733 8.5683 11.8336 19.46%
2002 11.2372 13.5238 14.0312 7.6295 9.9061 -26.63%
2001 12.0431 11.4452 13.7491 10.0502 13.5020 17.21%
2000 9.8563 8.1637 13.2586 6.9462 11.5195 36.01%
1999 10.1048 11.1934 12.2390 7.7701 8.4698 -24.72%
1998 9.3393 7.6201 11.4230 7.5353 11.2508 52.02%
1997 6.9096 5.5603 7.7542 5.5603 7.4011 32.12%
1996 4.9637 4.5044 6.2639 4.2031 5.6017 24.73%
1995 4.1154 3.4508 4.7879 3.3137 4.4909 30.64%
1994 3.0939 2.9608 3.5429 2.6952 3.4376 13.17%
1993 2.7224 3.0320 3.0761 2.3337 3.0376 0.18%
1992 3.0368 3.2884 3.3372 2.6648 3.0320 -9.97%
1991 2.5275 2.0709 3.3679 1.9139 3.3679 56.30%
1990 1.8109 1.6204 2.1787 1.4822 2.1547 35.42%
1989 1.3709 1.0906 1.6408 1.0717 1.5911 44.75%
1988 1.0588 1.0838 1.1652 0.9692 1.0992 2.21%
1987 1.2774 1.0460 1.4789 0.9584 1.0754 7.04%
1986 0.9597 0.7344 1.1867 0.6921 1.0047 36.06%
1985 0.5833 0.4272 0.7573 0.4219 0.7384 68.20%
1984 0.4462 0.4706 0.5008 0.3995 0.4390 -5.16%
1983 0.4611 0.3705 0.5422 0.3687 0.4629 19.27%
1982 0.3209 0.2704 0.4018 0.2541 0.3881 43.53%
1981 0.2828 0.2848 0.3167 0.2404 0.2704 -4.42%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $233.799B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $157.605B 39.46
Stryker (SYK) United States $150.214B 31.41
EssilorLuxottica (ESLOY) France $126.765B 0.00
Medtronic (MDT) Ireland $110.324B 15.64
Lonza Group Ag (LZAGY) Switzerland $50.804B 0.00
Haleon (HLN) United Kingdom $46.650B 26.61
ResMed (RMD) United States $37.413B 28.10
GE HealthCare Technologies (GEHC) United States $34.057B 16.17
Agilent Technologies (A) United States $33.852B 22.07
Terumo (TRUMY) Japan $27.835B 36.15
Koninklijke Philips (PHG) Netherlands $23.245B 16.31
Insulet (PODD) United States $22.033B 86.49
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Baxter (BAX) United States $15.595B 11.64
Smith & Nephew SNATS (SNN) United Kingdom $13.236B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.639B 23.10
Lantheus Holdings (LNTH) United States $5.638B 14.22
Prestige Consumer Healthcare (PBH) United States $3.998B 17.86
Perrigo (PRGO) Ireland $3.649B 9.25
Haemonetics (HAE) United States $3.545B 16.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.334B 27.70
ICU Medical (ICUI) United States $3.244B 23.92
GN Store Nord (GNNDY) Denmark $2.307B 19.11
QuidelOrtho (QDEL) United States $1.952B 13.43
LeMaitre Vascular (LMAT) United States $1.866B 41.70
AtriCure (ATRC) United States $1.598B 0.00
AdaptHealth (AHCO) United States $1.289B 13.08
Acuren (TIC) United States $1.271B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
Phibro Animal Health (PAHC) United States $1.040B 13.30
Neogen (NEOG) United States $1.027B 13.14
BioLife Solutions (BLFS) United States $1.021B 0.00
Kestra Medical Technologies (KMTS) United States $0.907B 0.00
InMode (INMD) Israel $0.897B 9.04
Owens & Minor (OMI) United States $0.685B 5.69
CeriBell (CBLL) United States $0.683B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.629B 0.00
Evolus (EOLS) United States $0.589B 0.00
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Valneva SE (VALN) France $0.494B 0.00
Surmodics (SRDX) United States $0.412B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
VAREX IMAGING (VREX) United States $0.354B 13.00
Quanterix (QTRX) United States $0.332B 0.00
SNDL (SNDL) Canada $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Viemed Healthcare (VMD) United States $0.274B 23.07
Cerus (CERS) United States $0.271B 0.00
ZimVie (ZIMV) United States $0.258B 11.72
Sanuwave Health (SNWV) United States $0.256B 0.00
Sanara MedTech (SMTI) United States $0.253B 0.00
Brainsway (BWAY) Israel $0.250B 66.10
Cresco Labs (CRLBF) United States $0.246B 0.00
Aurora Cannabis (ACB) Canada $0.233B 69.17
Biote (BTMD) United States $0.230B 6.46
OraSure Technologies (OSUR) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.224B 0.00
TriSalus Life Sciences (TLSI) United States $0.201B 0.00
Utah Medical Products (UTMD) United States $0.188B 15.29
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.184B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
Verano Holdings (VRNOF) United States $0.177B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.120B 0.00
Jin Medical (ZJYL) China $0.102B 0.00
Fonar (FONR) United States $0.092B 11.90
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Cytosorbents (CTSO) United States $0.077B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
MacroGenics (MGNX) United States $0.075B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Nephros (NEPH) United States $0.041B 55.14
United-Guardian (UG) United States $0.037B 12.94
Modular Medical (MODD) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.027B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00